Big European expansion for Abbott Diagnostics
This article was originally published in Clinica
Abbott Diagnostics is to invest E230m ($251m) in expanding manufacturing facilities in Ireland, the UK and Germany. The investment will also involve the creation of a new plant in Longford, Ireland. The developments will create 1,200 new jobs over five years, with half that figure to be recruited by the end of next year.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.